If you're presbyoptic or headed that way (and we all are) you may find this interesting.
Topical EV06 Improve Near Vision In Patients With Presbyopia
http://www.healio.co...with-presbyopia
Now, I'd tend to be pretty skeptical of that claim, but apparently Novartis has purchased the rights to EV06 from Texas based Encore Vision
Norvartis to buy topical presbyopia treatment
https://www.aao.org/headline/novartis-to-buy-topical-presbyopia-treatment
The involvement of Novartis tends to lend some credibility.
The claimed method of action is that EV06 breaks disulfide bonds in lens fiber cells to increase elasticity.
Quote from the article -
In a phase 1/2 masked, placebo-controlled, proof-of-concept study, 50 patients treated daily with 1 drop of EV06 showed improved distance corrected near vision at all time points measured, beginning as early as day 8. At the end of the 90-day study, almost twice the number of EV06 patients achieved 20/40 vision or 0.30 LogMAR compared to placebo (82% vs. 48%). EV06 was well tolerated.
And what is this miracle elixir you ask? It is a lipoic acid choline ester. Why, I think I might even cook that up at home given access to the patent.
Very interesting for presbyoptics. Let's hope the FDA doesn't drag there feet too much on this (who am I kidding, of course they'll drag their feet. It's the FDA.)